Skip to main content
Premium Trial:

Request an Annual Quote

Visible Genetics Gets Order for 100 Research DNA Sequencing Systems


TORONTO--Visible Genetics here received an order to build 100 DNA sequencing systems to the specifications of Swedish biotech supplier Amersham Pharmacia Biotech. The Seq4x4 system--designed to work with Amersham's exclusive one-color Cy5.5 terminator chemistry and Thermosequenase kits--is a 16-lane one-dye system that sequences 300 bases in under 30 minutes. It uses Visible Genetics' proprietary MicroCel technology and PC-based software designed by Visible for the Amersham market. Visible CEO John Stevens said the large order from the world's largest research-based biotech supplier to genomics research and pharmaceuticals development concerns will allow his company to focus its resources on sales and marketing of diagnostic software, instruments, systems and its HLA, HIV, and HPV GeneKits.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.